Framework agreement for Luspatercept

Summary

The tender concerns a framework agreement for Luspatercept supplies in Belgium (AZ Sint-Jan Brugge AV – Campus Sint-Jan). The objective is to secure Luspatercept under a framework agreement for the Belgian market. The maximum framework amount is EUR 2,255,587.20. The contract duration is from 2027-01-01 to 2030-12-31, with up to two extensions. The price is the only award criterion. The bidder must meet qualification requirements including providing proof of a valid professional liability insurance, proof of reimbursement by the RIZIV for the product with the date from which the reimbursement is valid, for each product include the scientific product information in pdf format, and FAGG registration for sale on the Belgian market; all documents must be valid at the bid opening date.